Use of molecular markers in samples obtained from preoperative aspiration of thyroid.
暂无分享,去创建一个
[1] A. Bartolazzi,et al. Methodology and Technical Requirements of the Galectin-3 Test for the Preoperative Characterization of Thyroid Nodules , 2012, Applied immunohistochemistry & molecular morphology : AIMM.
[2] Yasuhiro Ito,et al. Classification of thyroid follicular cell tumors: with special reference to borderline lesions. , 2012, Endocrine journal.
[3] A. Nassar,et al. HMGA2 Expression Analysis in Cytological and Paraffin-embedded Tissue Specimens of Thyroid Tumors by Relative Quantitative RT-PCR , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[4] W. Kim,et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. , 2011, The Journal of clinical endocrinology and metabolism.
[5] M. Henry,et al. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules , 2010, Cancer cytopathology.
[6] C. Ki,et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. , 2010, The Journal of clinical endocrinology and metabolism.
[7] D. Pacchioni,et al. Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining , 2010, Virchows Archiv.
[8] G. Fontanini,et al. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1. , 2010, Thyroid : official journal of the American Thyroid Association.
[9] Steven J. M. Jones,et al. Diagnostic utility of galectin-3 in thyroid cancer. , 2010, The American journal of pathology.
[10] M. Papotti,et al. Cyclin D1 and D3 overexpression predicts malignant behavior in thyroid fine‐needle aspirates suspicious for Hurthle cell neoplasms , 2009, Cancer.
[11] J. Fletcher,et al. Molecular Detection of PPARγ Rearrangements and Thyroid Carcinoma in Preoperative Fine-Needle Aspiration Biopsies , 2008, Endocrine pathology.
[12] P. Dalla Palma,et al. Expression of Cytokeratin 19 and Protein p63 in Fine Needle Aspiration Biopsy of Papillary Thyroid Carcinoma , 2008, Acta Cytologica.
[13] M. P. Martegani,et al. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. , 2008, The Lancet. Oncology.
[14] G. Troncone,et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings , 2007, Clinical endocrinology.
[15] S. Mukhopadhyay,et al. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining , 2006, Modern Pathology.
[16] B. Cho,et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto‐pathology diagnosis, especially in BRAFV600E mutation‐prevalent area , 2006, Clinical endocrinology.
[17] D. Wilbur,et al. The role of immunolocalization of CD57 and GLUT‐1 in cell blocks in fine‐needle aspiration diagnosis of papillary thyroid carcinoma , 2006, Cancer.
[18] David D. Roberts,et al. Proteomic Identification of New Biomarkers and Application in Thyroid Cytology , 2006, Acta Cytologica.
[19] X. Qian,et al. BRAF Mutation Analysis in Fine Needle Aspiration (FNA) Cytology of the Thyroid , 2006, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[20] S. Suster. Thyroid tumors with a follicular growth pattern: problems in differential diagnosis. , 2006, Archives of pathology & laboratory medicine.
[21] J. Collet,et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples , 2005, British Journal of Cancer.
[22] L. Mills,et al. Galectin‐3 is not useful in thyroid FNA , 2005, Cytopathology : official journal of the British Society for Clinical Cytology.
[23] M. Papotti,et al. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. , 2005, Endocrine-related cancer.
[24] M. Papotti,et al. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential , 2005, Modern Pathology.
[25] A. Gasbarri,et al. From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[26] M. Miettinen,et al. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours , 1996, Virchows Archiv.
[27] G. ClaudioLiberman,et al. Detección de marcadores de malignidad en nódulos tiroideos por transcripción reversa y reacción en cadena de la polimerasa (RT-PCR) , 2003 .
[28] A. Vecchione,et al. Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas. , 2003, Anticancer research.
[29] I. Goecke,et al. [Detection of malignancy markers in thyroid nodules by reverse transcriptase polymerase chain reaction (RT-PCR)]. , 2003, Revista médica de Chile (Impresa).
[30] T. Takano,et al. Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. , 2002, Endocrine journal.
[31] A Ippolito,et al. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy. , 2001, Thyroid : official journal of the American Thyroid Association.
[32] C. Cheung,et al. Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma , 2001, Modern Pathology.
[33] F. de Nigris,et al. FRA-1 expression in hyperplastic and neoplastic thyroid diseases. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] M. P. Martegani,et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] P. Soares,et al. Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Z. Baloch,et al. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. , 1999, Human pathology.
[37] A. Miyauchi,et al. Accurate and objective preoperative diagnosis of thyroid papillary carcinomas by reverse transcription-PCR detection of oncofetal fibronectin messenger RNA in fine-needle aspiration biopsies. , 1998, Cancer research.
[38] G. Botti,et al. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. , 1998, Cancer research.
[39] A. Kovatich,et al. Immunocytochemical evaluation of HBME‐1, CA 19‐9, and CD‐15 (Leu‐M1) in fine‐needle aspirates of thyroid nodules , 1998, Diagnostic cytopathology.
[40] C. Kandaraki,et al. Evaluation of HMFG2 and thyroglobulin in the diagnosis of thyroid fine needle aspiration (FNA) , 1997, Cytopathology : official journal of the British Society for Clinical Cytology.
[41] P. Ladenson,et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. , 1996, Archives of internal medicine.
[42] V. Alves,et al. Lactoferrin in thyroid lesions: immunoreactivity in fine needle aspiration biopsy samples. , 1996, Acta cytologica.
[43] M. Weiss,et al. Preoperative diagnosis of thyroid papillary carcinoma by reverse transcriptase polymerase chain reaction of the MUC1 gene , 1996, International journal of cancer.
[44] M. Ostrowski,et al. Leu‐7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms , 1995, Diagnostic cytopathology.